Prague, Czechia

Alexandra Silhankova


Average Co-Inventor Count = 10.4

ph-index = 4

Forward Citations = 44(Granted Patents)


Location History:

  • Prague, DK (1999)
  • Praha, CZ (1999 - 2000)
  • Phara, CZ (2000)
  • Praha 4, DK (2000)
  • Prague, CZ (1998 - 2003)

Company Filing History:


Years Active: 1998-2003

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations of Alexandra Silhankova

Introduction

Alexandra Silhankova is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 14 patents to her name, her work has garnered attention in both academic and industrial circles.

Latest Patents

Among her latest patents is the invention of N-Substituted azaheterocyclic compounds. This includes N-substituted azaheterocyclic carboxylic acids and esters thereof. The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters in which a substituted alkyl chain forms part of the N-substituent or salts thereof. It also covers methods for their preparation, compositions containing them, and their use for the clinical treatment of painful, hyperalgesic, and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.

Career Highlights

Throughout her career, Alexandra has worked with notable companies such as Novo Nordisk A/S and Novo Nordisk A/S. Her expertise in the field has allowed her to contribute to various innovative projects and research initiatives.

Collaborations

Alexandra has collaborated with esteemed colleagues, including Rolf Hohlweg and Knud Erik Andersen. These partnerships have further enhanced her research and development efforts.

Conclusion

Alexandra Silhankova's contributions to the field of chemistry and her innovative patents highlight her role as a leading inventor. Her work continues to impact the development of therapeutic compounds, showcasing her dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…